You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • OP0103 The effect of sirukumab plus methotrexate on circulating biomarkers of joint destruction in moderate to severe rheumatoid arthritis patients from the sirround-d phase 3 study

Article metrics

Article menu

Download PDFPDF

Oral Presentations
Progress in biological treatment of RA
OP0103 The effect of sirukumab plus methotrexate on circulating biomarkers of joint destruction in moderate to severe rheumatoid arthritis patients from the sirround-d phase 3 study
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20173002
Jul 20173203
Aug 20174803
Sep 201726011
Oct 20171804
Nov 20172404
Dec 20171606
Jan 20181201
Feb 20181601
Mar 20181902
Apr 20181600
May 20181800
Jun 2018600
Jul 2018801
Aug 2018800
Sep 2018800
Nov 2018201
Dec 2018401
Jan 2019100
Feb 2019003
Mar 2019003
Apr 2019001
May 2019001
Jun 2019201
Jul 2019202
Aug 2019403
Oct 2019204
Nov 2019203
Dec 2019600
Jan 2020001
Feb 2020201
Mar 2020002
Apr 2020200
May 2020802
Jun 2020800
Jul 2020601
Aug 2020003
Sep 20201000
Oct 2020801
Nov 2020601
Dec 20201000
Jan 2021001
Feb 2021002
Mar 2021201
Apr 2021201
May 2021003
Jun 2021003
Jul 2021004
Aug 2021002
Sep 2021002
Oct 20215015
Nov 2021208
Dec 2021602
Jan 2022200
Feb 2022601
Mar 2022001
Apr 2022400
May 20221007
Jun 2022202
Jul 20222200
Aug 20221204
Sep 2022208
Oct 2022603
Nov 20221002
Dec 2022600
Jan 20231001
Feb 2023200
Mar 2023800
May 2023002
Jul 2023204
Aug 2023201
Sep 2023001
Nov 2023501
Dec 20231000
Jan 2024200
Feb 2024900
Mar 2024201
Total5410156